84 related articles for article (PubMed ID: 1358053)
1. Symptomatic response to antipsychotics differs between recent onset and recurrent chronic schizophrenic patients.
Hill C; Keks NA; Jackson H; Kulkarni J; Hannah D; Copolov D; Singh B
Aust N Z J Psychiatry; 1992 Sep; 26(3):417-22. PubMed ID: 1358053
[TBL] [Abstract][Full Text] [Related]
2. Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness.
Haas GL; Garratt LS; Sweeney JA
J Psychiatr Res; 1998; 32(3-4):151-9. PubMed ID: 9793868
[TBL] [Abstract][Full Text] [Related]
3. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
Gomez JC; Crawford AM
J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753
[TBL] [Abstract][Full Text] [Related]
4. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
5. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
Kinon BJ; Roychowdhury SM; Milton DR; Hill AL
J Clin Psychiatry; 2001; 62 Suppl 2():17-21. PubMed ID: 11232746
[TBL] [Abstract][Full Text] [Related]
6. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
[TBL] [Abstract][Full Text] [Related]
7. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.
Mauri MC; Moliterno D; Rossattini M; Colasanti A
Schizophr Res; 2008 Feb; 99(1-3):7-12. PubMed ID: 18055177
[TBL] [Abstract][Full Text] [Related]
8. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
[TBL] [Abstract][Full Text] [Related]
9. Relation of familial schizophrenia to negative symptoms but not to the deficit syndrome.
Malaspina D; Goetz RR; Yale S; Berman A; Friedman JH; Tremeau F; Printz D; Amador X; Johnson J; Brown A; Gorman JM
Am J Psychiatry; 2000 Jun; 157(6):994-1003. PubMed ID: 10831482
[TBL] [Abstract][Full Text] [Related]
10. [Prediction of therapeutic success in acute neuroleptic treatment: results of an empirical study of 243 inpatient-treated schizophrenic patients].
Möller HJ; Scharl W; von Zerssen D
Fortschr Neurol Psychiatr; 1985 Oct; 53(10):370-83. PubMed ID: 2866152
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine in augmentation of antipsychotic response in chronic schizophrenia: a negative pilot report.
Wells BG; Chu CC; Abi-Darghum A; Saini TS
Pharmacopsychiatry; 1991 Jul; 24(4):118-20. PubMed ID: 1684441
[TBL] [Abstract][Full Text] [Related]
12. Age of illness onset and schizophrenic symptomatology during an inpatient washout period.
Sharma RP; Dowd SM; Davis JM; Janicak PG
Schizophr Res; 1996 Jul; 20(3):295-300. PubMed ID: 8827856
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of antipsychotic response in schizophrenia.
Correll CU; Malhotra AK; Kaushik S; McMeniman M; Kane JM
Am J Psychiatry; 2003 Nov; 160(11):2063-5. PubMed ID: 14594760
[TBL] [Abstract][Full Text] [Related]
14. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia].
Loas G; Noisette C; Legrand A; Boyer P; Delahousse J
Encephale; 1996; 22(5):351-8. PubMed ID: 9035991
[TBL] [Abstract][Full Text] [Related]
16. Zotepine in the treatment of negative symptoms in chronic schizophrenia.
Fleischhacker WW; Barnas C; Stuppäck C; Unterweger B; Hinterhuber H
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):58-60. PubMed ID: 2883684
[TBL] [Abstract][Full Text] [Related]
17. MMPI discriminators of deficit vs. non-deficit recent-onset schizophrenia patients.
Subotnik KL; Nuechterlein KH; Ventura J
Psychiatry Res; 2000 Mar; 93(2):111-23. PubMed ID: 10725528
[TBL] [Abstract][Full Text] [Related]
18. Standard olanzapine versus placebo and ineffective-dose olanzapine in the maintenance treatment of schizophrenia.
Dellva MA; Tran P; Tollefson GD; Wentley AL; Beasley CM
Psychiatr Serv; 1997 Dec; 48(12):1571-7. PubMed ID: 9406266
[TBL] [Abstract][Full Text] [Related]
19. [Evolution of the social autonomy scale (EAS) in schizophrenic patients depending on their management].
Leguay D; Rouillon F; Azorin JM; Gasquet I; Loze JY; Arnaud R; Dillenschneider A
Encephale; 2010 Oct; 36(5):397-407. PubMed ID: 21035630
[TBL] [Abstract][Full Text] [Related]
20. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
Thompson PA; Buckley PF; Meltzer HY
J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
